United Therapeutics Corp (UTHR) - Medical Equipment - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The companys products consist of prostacyclin analogues including Remodulin (treprostinil) injection and Tyvaso (treprostinil) inhalation solution; and Orenitram (treprostinil). Adcirca (tadalafil) is a phosphodiesterase type 5 (PDE-5) inhibitor and Unituxin (dinutuximab) is used for monoclonal antibody for oncologic applications are the other products. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents and cell-based therapies. The company is also developing engineered lungs for transplantation in pre-clinical stage. The company manufactures its products in its facility in Silver Spring, Maryland. It operates in the US and markets its products across Europe, South America and Israel. UTC is headquartered in Maryland, the US.
United Therapeutics Corp (UTHR) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The companys products consist of prostacyclin analogues including Remodulin (treprostinil) injection and Tyvaso (treprostinil) inhalation solution; and Orenitram (treprostinil). Adcirca (tadalafil) is a phosphodiesterase type 5 (PDE-5) inhibitor and Unituxin (dinutuximab) is used for monoclonal antibody for oncologic applications are the other products. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents and cell-based therapies. The company is also developing engineered lungs for transplantation in pre-clinical stage. The company manufactures its products in its facility in Silver Spring, Maryland. It operates in the US and markets its products across Europe, South America and Israel. UTC is headquartered in Maryland, the US.
United Therapeutics Corp (UTHR) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
United Therapeutics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
United Therapeutics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
United Therapeutics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
United Therapeutics Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
United Therapeutics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
United Therapeutics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Respira Therapeutics to Raise Funds through Series B Preferred Stock Financing 10
TransMedics Raises USD51.2 Million in Equity Financing Round 10
Partnerships 12
United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 12
Northwell Health Enters into Partnership with United Therapeutics 12
Lung Biotech Enters into Co-Development Agreement with EHang 13
United Therapeutics Enters into Agreement with Deka for Remodulin Delivery System 14
Acquisition 15
Emergent BioSolutions Acquires Unither Virology from United Therapeutics 15
United Therapeutics Acquires Revivicor for up to USD29.2 Million 15
United Therapeutics Divests Majority Stake In Medicomp 16
United Therapeutics Corp - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Apr 26, 2017: United Therapeutics Reports First Quarter 2017 Financial Results 22
Feb 22, 2017: United Therapeutics Reports 2016 Fourth Quarter And Annual Financial Results 23
Oct 27, 2016: United Therapeutics Reports Third Quarter 2016 Financial Results 24
Jul 28, 2016: United Therapeutics Reports Second Quarter 2016 Financial Results 25
Apr 28, 2016: United Therapeutics Reports First Quarter 2016 Financial Results 26
Feb 25, 2016: United Therapeutics Corporation Reports 2015 Fourth Quarter And Annual Financial Results 27
Corporate Communications 29
Apr 28, 2016: United Therapeutics Announces Executive Leadership Changes 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30
List Of Tables
United Therapeutics Corp, Medical Equipment, Key Facts, 2016 1
United Therapeutics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
United Therapeutics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
United Therapeutics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
United Therapeutics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
United Therapeutics Corp, Deals By Market, 2011 to YTD 2017 8
United Therapeutics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Respira Therapeutics to Raise Funds through Series B Preferred Stock Financing 10
TransMedics Raises USD51.2 Million in Equity Financing Round 10
United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 12
Northwell Health Enters into Partnership with United Therapeutics 12
Lung Biotech Enters into Co-Development Agreement with EHang 13
United Therapeutics Enters into Agreement with Deka for Remodulin Delivery System 14
Emergent BioSolutions Acquires Unither Virology from United Therapeutics 15
United Therapeutics Acquires Revivicor for up to USD29.2 Million 15
United Therapeutics Divests Majority Stake In Medicomp 16
United Therapeutics Corp, Key Competitors 18
United Therapeutics Corp, Key Employees 19
United Therapeutics Corp, Other Locations 20
United Therapeutics Corp, Subsidiaries 20
List Of Figures
United Therapeutics Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
United Therapeutics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
United Therapeutics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
United Therapeutics Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
United Therapeutics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
United Therapeutics Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
United Therapeutics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
United Therapeutics Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
RELATED REPORTS
Clinical Laboratory Services Market in United States - 2023 Edition
Clinical laboratories are healthcare facilities providing a wide range of laboratory procedures which aid the physicians in carrying out the diagnosis, treatment, and management of patients. Laboratory services are provided
View ReportUnited Kingdom Spinal Surgery Market Outlook to 2025 - Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices
United Kingdom Spinal Surgery Market Outlook to 2025 - Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices United Kingdom Spinal
View ReportUnited Therapeutics Full Year Operating Financial
United Therapeutics 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Biotechnology Industry This report is part of the
View ReportUnited Therapeutics 2023 Third Quarter Operating and Financial Review
United Therapeutics 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Biotechnology IndustryThis report is part of the Competitive Analysis
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
